Syndrome News and Research

RSS

Polycystic ovary syndrome in women can be relieved by acupuncture and exercise

Polycystic ovary syndrome, a common condition among women, can be relieved by the use of acupuncture and exercise. This has been shown by a recent study at the Sahlgrenska Academy, University of Gothenburg, Sweden.

27 Aug 2009

New technique for diabetes treatment may be in the offing

An exploration of the molecular links between insulin resistance and inflammation may have revealed a novel target for diabetes treatment, say scientists at the John G. Rangos Sr. Research Center, Children's Hospital of Pittsburgh of UPMC. Their findings were published earlier this month in the online version of Diabetes, one of the journals of the American Diabetes Association.

27 Aug 2009

Clinical study results of USANA Health Sciences products published in the Obesity and Weight Management journal

USANA Health Sciences, Inc. announced today that results of a large, third-party clinical study involving USANA products, conducted at the University of Colorado Denver (UCD), have been published in the August 2009 edition of the journal Obesity and Weight Management.

26 Aug 2009

Positive results obtained from phase 3 clinical trial of lurasidone for treating schizophrenia

Dainippon Sumitomo Pharma Co., Ltd., (DSP) announced today positive results from PEARL 2 - a phase 3 clinical trial of lurasidone for the treatment of patients with schizophrenia. In this trial, both lurasidone 40 and 120 mg/day were significantly more effective than placebo for the treatment of schizophrenia. Lurasidone was well-tolerated with an overall discontinuation rate that was similar to placebo.

26 Aug 2009

Research study concludes the difference in mortality between men and women depending on the type of ACS

A new study from NYU School of Medicine found that women may have a slightly higher risk of death than men in the thirty days following an acute coronary syndrome (ACS), but that these differences appear to be attributable to factors such as severity and type of ACS.

26 Aug 2009

Phase III RE-LY study results to be presented at the European Society of Cardiology Congress

Results of the Phase III RE-LY(R) (Randomized Evaluation of Long-Term Anticoagulant Therapy, Warfarin, Compared to Dabigatran) study will be presented at the European Society of Cardiology (ESC) Congress in Barcelona on Sunday, Aug. 30. The primary objective of RE-LY was to assess the safety and efficacy of the investigational oral direct thrombin inhibitor, dabigatran etexilate, against the current standard therapy, warfarin, for the prevention of stroke in patients with atrial fibrillation (AF).

26 Aug 2009

Bederra Corporation's six-month financial statements show an operating loss

Bederra Corporation (PINKSHEETS: BEDA), a Houston, Texas based diversified medical services provider, recently published its six months results on www.pinksheets.com.

26 Aug 2009

Women face higher risk of mortality rate following acute coronary syndromes

Women may have a slightly higher risk of death than men in the 30 days following an acute coronary syndrome (ACS; such as heart attack or unstable angina), but this difference appears attributable to factors such as severity and type of ACS, clinical differences and angiographic severity according to a study in the August 26 issue of JAMA.

26 Aug 2009

Mutations of gene regulators can result in growth disorders

A specific gene is particularly frequently involved in the development of short stature. Researchers in Heidelberg have now discovered that sequences of genetic material on the X and Y chromosome that regulate this gene are also crucial for growth in children.

26 Aug 2009

Neurogen stockholders to receive $11 million in Ligand Pharmaceuticals common stock as part of acquisition deal

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) and Neurogen Corporation (NASDAQ:NRGN) announced today they have entered into a definitive merger agreement under which Ligand will acquire Neurogen. Under the transaction, Neurogen stockholders will receive an estimated $11 million in Ligand common stock and will be granted Contingent Value Rights (“CVRs”) under four CVR agreements.

25 Aug 2009

Researchers identify causative gene for features of 2q32q33 microdeletion syndrome

...

24 Aug 2009

Phase 2 clinical study of Resolvin RX-10045 for dry eye syndrome provides positive data

Resolvyx Pharmaceuticals, Inc., the leading resolvin therapeutics company, today announced positive data from a Phase 2 clinical study evaluating RX-10045, a resolvin administered as a topical eye drop for the treatment of patients with chronic dry eye syndrome.

24 Aug 2009

SRC's Benefit Concert for disabled people to be held at Journey of Faith Church

The Sensory Research Center (SRC) invites you to a Benefit Concert, Dessert and Auction, featuring LA Collaboration, at Journey of Faith Church in Manhattan Beach, 1243 Artesia Blvd, Manhattan Beach, CA - (310) 372-4641 at 7:00 PM. Mention this article and receive 2 for the price of 1 tickets.

21 Aug 2009

New book reveals information on the occurrence and spread of rabies in bats

Bat Rabies is intended for scientists and the general public. Dr. Constantine presents the material in a simple, straightforward manner that serves both audiences. The book, prepared by the U.S. Geological Survey National Wildlife Health Center, was published with the goal of increasing public understanding of rabies and the often misunderstood bat, and providing a balanced perspective on the risk of bat rabies to people.

21 Aug 2009

Research reveals brain activity networks of Alzheimer's disease affected patients become more random and unstructured

Different types of dementia show dissimilar changes in brain activity. A network mapping technique described in the open access journal BMC Neuroscience has been applied to EEG data obtained from patients with Alzheimer's disease (AD) and frontotemporal lobar degeneration (FTLD, a less common type of dementia with more prominent behavioral symptoms).

21 Aug 2009

Research attributes accumulation of belly fat to change in hormone balance during menopause transition

In middle-aged women, visceral fat, more commonly called belly fat, is known to be a significant risk factor for cardiovascular disease, but what causes visceral fat to accumulate?

21 Aug 2009

Role of HPRT genes detected in Lesch Nyan X-linked inherited disorders

A study from the Center for Molecular Genetics at the University of California, San Diego School of Medicine shows that a gene called HPRT plays an important role in setting the program by which primitive or precursor cells decide to become normal nerve cells in the human brain. This unconventional view of metabolic genes known as "housekeeping" genes is now online at the journal Molecular Therapy.

21 Aug 2009

FDA approves Hiberix Haemophilus influenzae type b vaccine

In response to a U.S. shortage of a vaccine to protect infants from Haemophilus influenzae type b (Hib), GlaxoSmithKline (NYSE: GSK) has received accelerated approval from the FDA (Food and Drug Administration) for Hiberix((R)) [Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate)] as a booster dose in children 15 months through four years of age. Hib is an often severe and potentially deadly bacterial infection that can cause meningitis.

19 Aug 2009

Brain's motor and perception regions disconnected in tone-deaf people

Nerve fibers that link perception and motor regions of the brain are disconnected in tone-deaf people, according to new research in the August 19 issue of The Journal of Neuroscience. Experts estimate that at least 10 percent of the population may be tone deaf - unable to sing in tune. The new finding identifies a particular brain circuit that appears to be absent in these individuals.

19 Aug 2009

CSL Biotherapies to supply Afluria influenza vaccines from newly licensed packaging facility

CSL Biotherapies, a subsidiary of CSL Limited, one of the world's leading manufacturers of influenza vaccine, announced today that the U.S. Food and Drug Administration (FDA) has licensed the company’s newest vaccine filling and packaging facility, located in Kankakee, Ill. The facility, part of an investment to expand CSL’s U.S. influenza vaccine production capabilities, includes a high-speed, single-dose vaccine syringe filling line.

19 Aug 2009

Syndrome News and Research

Polycystic ovary syndrome in women can be relieved by acupuncture and exercise

New technique for diabetes treatment may be in the offing

Clinical study results of USANA Health Sciences products published in the Obesity and Weight Management journal

Positive results obtained from phase 3 clinical trial of lurasidone for treating schizophrenia

Research study concludes the difference in mortality between men and women depending on the type of ACS

Phase III RE-LY study results to be presented at the European Society of Cardiology Congress

Bederra Corporation's six-month financial statements show an operating loss

Women face higher risk of mortality rate following acute coronary syndromes

Mutations of gene regulators can result in growth disorders

Neurogen stockholders to receive $11 million in Ligand Pharmaceuticals common stock as part of acquisition deal

Researchers identify causative gene for features of 2q32q33 microdeletion syndrome

Phase 2 clinical study of Resolvin RX-10045 for dry eye syndrome provides positive data

SRC's Benefit Concert for disabled people to be held at Journey of Faith Church

New book reveals information on the occurrence and spread of rabies in bats

Research reveals brain activity networks of Alzheimer's disease affected patients become more random and unstructured

Research attributes accumulation of belly fat to change in hormone balance during menopause transition

Role of HPRT genes detected in Lesch Nyan X-linked inherited disorders

FDA approves Hiberix Haemophilus influenzae type b vaccine

Brain's motor and perception regions disconnected in tone-deaf people

CSL Biotherapies to supply Afluria influenza vaccines from newly licensed packaging facility

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News